BR112023023128A2 - Formulação de sotorasib - Google Patents

Formulação de sotorasib

Info

Publication number
BR112023023128A2
BR112023023128A2 BR112023023128A BR112023023128A BR112023023128A2 BR 112023023128 A2 BR112023023128 A2 BR 112023023128A2 BR 112023023128 A BR112023023128 A BR 112023023128A BR 112023023128 A BR112023023128 A BR 112023023128A BR 112023023128 A2 BR112023023128 A2 BR 112023023128A2
Authority
BR
Brazil
Prior art keywords
sotorasib
formulation
disintegrant
diluent
lubricant
Prior art date
Application number
BR112023023128A
Other languages
English (en)
Inventor
Angela Olsofsky
E Houk Brett
Paul Daurio Dominick
Antonio Alvarez-Nunez Fernando
Jiemin Bao
Naga Duggirala
Namita Sawant
Prasant Chamarthy Sai
Yuan-Hon Kiang
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of BR112023023128A2 publication Critical patent/BR112023023128A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

formulação de sotorasib. a divulgação proporciona formulações compreendendo sotorasib (1), um diluente, um desintegrante e um lubrificante.
BR112023023128A 2021-05-06 2022-05-05 Formulação de sotorasib BR112023023128A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163184941P 2021-05-06 2021-05-06
US202163212316P 2021-06-18 2021-06-18
PCT/US2022/027830 WO2022235904A1 (en) 2021-05-06 2022-05-05 Sotorasib formulation

Publications (1)

Publication Number Publication Date
BR112023023128A2 true BR112023023128A2 (pt) 2024-01-30

Family

ID=81748639

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023023128A BR112023023128A2 (pt) 2021-05-06 2022-05-05 Formulação de sotorasib

Country Status (15)

Country Link
US (1) US20240226020A1 (pt)
EP (1) EP4333813A1 (pt)
JP (1) JP2024516441A (pt)
KR (1) KR20240004589A (pt)
AU (1) AU2022270124A1 (pt)
BR (1) BR112023023128A2 (pt)
CA (1) CA3218087A1 (pt)
CL (1) CL2023003289A1 (pt)
CO (1) CO2023015033A2 (pt)
CR (1) CR20230526A (pt)
IL (1) IL307849A (pt)
MX (1) MX2023012930A (pt)
TW (1) TW202308640A (pt)
UY (1) UY39758A (pt)
WO (1) WO2022235904A1 (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3738593A1 (en) * 2019-05-14 2020-11-18 Amgen, Inc Dosing of kras inhibitor for treatment of cancers

Also Published As

Publication number Publication date
CR20230526A (es) 2024-01-08
KR20240004589A (ko) 2024-01-11
TW202308640A (zh) 2023-03-01
US20240226020A1 (en) 2024-07-11
MX2023012930A (es) 2023-11-13
UY39758A (es) 2022-11-30
CA3218087A1 (en) 2022-11-10
JP2024516441A (ja) 2024-04-15
IL307849A (en) 2023-12-01
CL2023003289A1 (es) 2024-04-12
CO2023015033A2 (es) 2023-11-20
WO2022235904A1 (en) 2022-11-10
AU2022270124A1 (en) 2023-11-02
EP4333813A1 (en) 2024-03-13

Similar Documents

Publication Publication Date Title
CL2021002880S1 (es) Estuche de auriculares. (divisional solicitud 202000595)
CL2022000027A1 (es) Compuestos antagonistas de pcsk9. (divisional de solicitud 202003257).
CL2021002465A1 (es) Composiciones pesticidas (divisional de solicitud 202003102).
DE602008004356D1 (de) Konservierungsmittelfreie augenlösung auf prostaglandin-basis
DOP2006000050A (es) Una formulación sólida de dosificación farmaceútica
CL2020003047S1 (es) Interfaz de herramienta eléctrica. (divisional de solicitud 201903643)
CL2021001956A1 (es) Formulaciones de inmunoconjugado anti-cd79b estables. (divisional solicitud 202002624)
MX2021006674A (es) Composiciones para estabilizar bacterias y usos de las mismas.
CY1122829T1 (el) Φαρμακευτικη συνθεση για νευροπαθητικο πονο
JP2022102688A5 (pt)
JPWO2021193234A5 (pt)
BR112018010456A2 (pt) ?composição, método para limpeza ou desinfecção de uma superfície e uso de uma composição?
MX2022013644A (es) Composicion que contiene aceite de fluor.
BR112023002923A2 (pt) Formulação farmacêutica que compreende um bite, anticorpo bespecífico, e metionina
BR112023023128A2 (pt) Formulação de sotorasib
AR125801A1 (es) Formulación de sotorasib
CL2020003049S1 (es) Interfaz de herramienta eléctrica. (divisional de solicitud 201903646)
BR112021021093A2 (pt) Graxas lubrificantes compreendendo sabões de metais e sabões de complexos de metais à base de ácido r-10-hidroxioctadecanóico
BR112022016359A2 (pt) Formas cristalinas de um composto farmacêutico
JP2023130812A5 (pt)
MX2023008406A (es) Formulacion farmaceutica.
FR3087089B1 (fr) Composition desinfectante a usage topique
BR112018073649A2 (pt) agente de controle de espuma de poliéter, formulação agroquímica, e, processo para preparar uma formulação agroquímica.
CL2020000618S1 (es) Cabezal de cepillo de dientes. (divisional solicitud 201900807)
CL2020000620S1 (es) Cabezal de cepillo de dientes. (divisional solicitud 201900808)